Trans-Sodium Crocetinate

DRUG2 trials

Sponsors

Diffusion Pharmaceuticals Inc

Conditions

Healthy SubjectsStroke, Acute

Phase 1

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers

CompletedNCT04808622

Diffusion Pharmaceuticals IncHealthy Subjects

Start: 2021-03-17End: 2021-03-25Updated: 2023-07-11

Phase 2

Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

TerminatedNCT03763929

Diffusion Pharmaceuticals IncStroke, Acute

Start: 2019-08-22End: 2020-10-19Updated: 2021-06-18